Heres some early info from testing: In the study, people taking orforglipron saw their A1C levels drop by 1.3% to 1.6%, and those on the highest dose lost an average of 16 pounds (7.9%)
Patient selection criteria are not well-established, and determining which patients are most likely to benefit from these therapies requires clinical judgment based on limited evidence
Randomized, double-blind, phase 3 trial of triple therapy with dapagliflozin add-on to saxagliptin plus metformin in type 2 diabetes
However, if you're deficient in vitamin B12, your doctor might recommend B12 shots more frequently up to twice a week to help with energy and fat metabolism
The subcutaneous fatty tissue in specific body areasabdomen, thigh, and upper armoffers the most reliable absorption rates for semaglutide and other injectable peptides, with clinical data showing consistent pharmacokinetics when patients rotate injection sites properly